Democratizing Clinical Trials with Dana Dornsife of Lazarex Cancer Foundation

Dana Dornsife is a designer turned philanthropist whose activities help people the world over. When tragedy struck close to home, she started the Lazarex Foundation, which she founded in order to connect people with clinical trials and help the economically disadvantaged to be able to capitalize on trials that they might not otherwise have access. In the development of the foundation, she realized the large racial gap that exists in clinical trials, so we discuss that and how her foundation is trying to close it. We also discuss her inspiration for starting the foundation and the federal regulations she had to overcome in order to help the economically disadvantaged.

In addition to Lazarex, she supports World Vision, an international humanitarian agency, through which she supports microeconomic enterprise, agriculture and literacy programs in the Islamic Republic of Mauritania and, in partnership with the Conrad N. Hilton Foundation, well-water drilling in Mali, Ghana, Niger, Ethiopia, Zambia and Malawi. She is also a supporter of the Alzheimer’s Association Cerebrospinal Fluid Quality (CSF) Control Program, launched in 2009, that brought together world laboratories with the aim of standardizing the measurement potential of Alzheimer biomarkers in CSF. She also serves on the Board of Directors of Epeius Biotechnologies, Inc., a biopharmaceutical company developing genetic medicine for the treatment of cancer. She is also actively involved at the USC Dornsife College of Letters, Arts and Sciences.

Find this and all episodes on your favorite podcast platform at

Please be sure to leave a five-star review, a nice comment and SHARE!!!

Leave a Reply

Your email address will not be published. Required fields are marked *